Molecular Development of the Endolymphatic Duct and Sac
Molecular Development of the Endolymphatic Duct and Sac
批准号:
6860096
负责人:
DANIEL I CHOO
金额:
$16.72万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-02 至 2006-09-30
关键词:
Meniere&aposs diseasebiological modelsbiological signal transductioncell differentiationdevelopmental geneticsembryo /fetusendolymphgene expressiongene induction /repressiongene targetinggenetic markersgenetically modified animalshearing disordershistogenesishistologyhomeostasisimmunocytochemistryin situ hybridizationlaboratory mouselabyrinthmicroinjectionsmodel design /developmentotocyst /otolithrhombencephalontissue /cell culturetransfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (from applicant's abstract): Homeostasis of inner ear endolymph is
critical to sensory transduction in the inner ear. Failure to maintain
endolymph homeostasis is thought to result in deafness, vestibular dysfunction
and tinnitus in pathologies such as Meniere's disease or certain forms of
hereditary hearing impairment. The endolymphatic duct and sac (ELDS) are key
structures in maintaining this fluid homeostasis. Therefore, data on the
molecular development of the ELDS are very relevant. By focusing on a mouse
mutant (kreisler) with an ELDS phenotype, this application seeks to define the
molecular pathways involved in induction and differentiation of the ELDS. To
determine early targets of kr signaling, this application will test the
hypothesis that expression of early molecular markers of the ELDS anlage is
down-regulated in homozygote kr embryos at embryonic day 10-11 compared to
controls. The effects of kr mutation on cellular differentiation within the
developing ELDS will be studied by testing the hypothesis that expression of a
battery of genes specific for cells in the embryonic day 12 to 18 ELDS is
down-regulated in kreisler homozygotes compared to controls. To facilitate
direct experimental manipulation of the developing ELDS, this application will
develop an in vitro model of the developing kreisler otocyst and ELDS.
Experiments will first test the hypothesis that cultured kreisler otocysts
developmentally mimic the in vivo system morphologically and functionally. This
model will then be used to test the hypothesis that virally mediated expression
of kr can rescue the ELDS phenotype in vitro. To test the hypothesis that
hindbrain sources of kr induce ELDS differentiation, we will culture kreisler
otocysts with wild-type hindbrain explants. Such data will provide insights
into the molecular pathways involved in kr signaling and in development of the
ELDS. The PI's obvious commitment to medicine and science has been demonstrated
by his extensive pursuit of training in the clinical and basic science facets of
inner ear biology. The success of these efforts are reflected in his
publications which also demonstrate his ability to accomplish quality basic
science investigation. In combination with the outstanding academic environment
at Children's Hospital Research Foundation, the RCA will allow the PI to
continue a rigorous scientific training and successfully address the specific
aims outlined in the application. The proposed program of study and the science
generated will undoubtedly advance the PI toward his goals of successfully
competing for a future R01, and in the long term, becoming a successful
independent Clinician scientist. Significantly, this proposal includes
challenging but achievable goals that will provide important knowledge to the
field of inner ear development.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:7850287
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2009
-
负责人:DANIEL I CHOO
-
依托单位:
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:8011365
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2007
-
负责人:DANIEL I CHOO
-
依托单位:
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:7744628
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2007
-
负责人:DANIEL I CHOO
-
依托单位:
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:7334715
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2007
-
负责人:DANIEL I CHOO
-
依托单位:
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:7190696
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2007
-
负责人:DANIEL I CHOO
-
依托单位:
A preclinical trial of intratympanic antivirals for CMV-related hearing loss
-
批准号:7545889
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2007
-
负责人:DANIEL I CHOO
-
依托单位:
Molecular Development of the Endolymphatic Duct and Sac
-
批准号:6331871
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2001
-
负责人:DANIEL I CHOO
-
依托单位:
Molecular Development of the Endolymphatic Duct and Sac
-
批准号:6634419
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2001
-
负责人:DANIEL I CHOO
-
依托单位:
Molecular Development of the Endolymphatic Duct and Sac
-
批准号:6516034
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2001
-
负责人:DANIEL I CHOO
-
依托单位:
Molecular Development of the Endolymphatic Duct and Sac
-
批准号:6745556
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2001
-
负责人:DANIEL I CHOO
-
依托单位:
HEARING AND BALANCE FUNCTION AND PRESERVATION IN INNER EAR DISEASE
-
批准号:6289647
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DANIEL I CHOO
-
依托单位:
Hearing and Balance Function and Preservation in Inner Ear Disease
-
批准号:6104234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DANIEL I CHOO
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: